Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: PLoS Genetics, 9, 3, S.
- Event
-
Veröffentlichung
- (where)
-
Augsburg, San Francisco
- (who)
-
Universität Augsburg, Public Library of Science
- (when)
-
2013
- Creator
- DOI
-
10.1371/journal.pgen.1003212
- URN
-
urn:nbn:de:bvb:384-opus4-843893
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:41 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Couch, F. J.
- Wang, X.
- Ditsch, Nina
- Universität Augsburg, Public Library of Science
Time of origin
- 2013
Other Objects (12)
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways
Germline RAD51C mutations confer susceptibility to ovarian cancer
PET-CT in recurrent ovarian cancer: impact on treatment planning
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways
Germline RAD51C mutations confer susceptibility to ovarian cancer
PET-CT in recurrent ovarian cancer: impact on treatment planning
Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer
Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways
Germline RAD51C mutations confer susceptibility to ovarian cancer